世界の細胞培養市場2022-2029:消耗品別(培地、血清、試薬)、製品別、用途別、地域別

【英語タイトル】Global Cell Culture Market Size study & Forecast, by Consumable (Media, Sera, Reagents), by Product (Culture Systems, Incubators, Centrifuges, Cryostorage Equipment, Biosafety Equipment, Pipetting Instruments), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Others) and Regional Analysis, 2022-2029

Bizwit Research & Consultingが出版した調査資料(BZW22DV053)・商品コード:BZW22DV053
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年10月8日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社は、2021年におよそXX億ドルであった世界の細胞培養市場規模が、2022年から2029年の間にXX%以上成長すると予測しています。当調査資料は、細胞培養の世界市場を総合的に調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、消耗品別(培地、血清、試薬)分析、製品別(培養システム、インキュベーター、遠心分離機、凍結保存装置、バイオセーフティ機器)分析、用途別(バイオ医薬品、組織培養&組織工学、ワクチン製造、医薬品開発、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他地域)分析、競争分析、調査プロセスなど、以下の構成でまとめております。なお、当書には、Novo Nordisk A/S、Eli Lilly and Company、Sanofi、Biocon Ltd、Wockhardt、Boehringer Ingelheim International GmbH、Julphar、United Laboratories International Holdings Limited、Tonghua Dongbao Pharmaceutical Co. Ltd.、Pfizerなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の細胞培養市場規模:消耗品別(培地、血清、試薬)
・世界の細胞培養市場規模:製品別
- 培養システムの市場規模
- インキュベーターの市場規模
- 遠心分離機の市場規模
- 凍結保存装置の市場規模
- バイオセーフティ機器の市場規模
・世界の細胞培養市場規模:用途別
- バイオ医薬品における市場規模
- 組織培養&組織工学における市場規模
- ワクチン製造における市場規模
- 医薬品開発における市場規模
- その他用途における市場規模
・世界の細胞培養市場規模:地域別
- 北米の細胞培養市場規模
- ヨーロッパの細胞培養市場規模
- アジア太平洋の細胞培養市場規模
- 中南米の細胞培養市場規模
- その他地域の細胞培養市場規模
・競争分析
・調査プロセス

Global Cell Culture Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Cell culture is a method of growing cells under controlled conditions, usually outside their natural environment. The cells of interest can then be maintained under carefully monitored conditions after being removed from living tissue. The cell removal from the tissues is performed by mechanical or enzymatic method before cultivation. The surging demand for personalized medicine, rising emphasis on monoclonal antibodies, increasing funding for cell-based research, coupled with the growing awareness about the benefits of cell-based vaccines are the key factors that are propelling the market demand across the globe.

According to Statista, in 2019, the global market for personalized medicine market was estimated to be worth around USD 1,980 billion, which is projected to reach USD 2,770 billion by the year 2022. Consequentially, the thriving demand for personalized medicine is accelerating the growth of the Cell Culture Market. In addition, the increasing demand for 3D cell culture, as well as the launch of advanced cell culture products are presenting various growth prospects for the market expansion in the forthcoming years. However, limitations associated with the production of high-density cell cultures and the high cost of cell biology research are hampering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cell Culture Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the increasing number of regulatory approvals for cell culture-based vaccines, higher investments in cell-based research, along with growing technological advancements. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising incidence of diseases such as cancer, growth in the biotechnology & pharmaceutical industries, and strong government support.

Major market players included in this report are:
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon Ltd
Wockhardt
Boehringer Ingelheim International GmbH
Julphar
United Laboratories International Holdings Limited
Tonghua Dongbao Pharmaceutical Co. Ltd.
Pfizer

Recent Developments in the Market:
 For instance, in January 2022, BioIVT announced the introduction of the company’s GMP Grade Human AB Serum that is specialized in gene therapy manufacturing.
 In October 2021, Thermo Fisher Scientific Inc. (US) unveiled the launched the Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which helps in promoting large-scale growth and culture of functional natural killer (NK) cells without or with the usage of feeder cells.
 In September 2021, Cytiva proclaims the expansion of its manufacturing capacity for bioprocessing single-use consumables by introducing 3 new manufacturing facilities within ten months.

Global Cell Culture Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Consumable, Product, ApplicationApplication, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Consumable:
Media
Sera
Reagents

By Product:
Culture Systems
Incubators
Centrifuges
Cryostorage Equipment
Biosafety Equipment
Pipetting Instruments

By Application:
Biopharmaceuticals
Tissue Culture & Engineering
Vaccine Production
Drug Development
Gene Therapy
Cancer Research
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Cell Culture Market, by Region, 2019-2029 (USD Billion)
1.2.2. Cell Culture Market, by Consumable, 2019-2029 (USD Billion)
1.2.3. Cell Culture Market, by Product, 2019-2029 (USD Billion)
1.2.4. Cell Culture Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell Culture Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell Culture Market Dynamics
3.1. Cell Culture Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Surging demand for the personalized medicine
3.1.1.2. Increasing funding for cell-based research
3.1.2. Market Challenges
3.1.2.1. Limitations in the Consumableion of high-density cell cultures
3.1.2.2. High cost of cell biology research
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for 3D cell culture
3.1.3.2. Launch of advanced cell culture Consumables
Chapter 4. Global Cell Culture Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cell Culture Market, by Consumable
6.1. Market Snapshot
6.2. Global Cell Culture Market by Consumable, Performance – Potential Analysis
6.3. Global Cell Culture Market Estimates & Forecasts by Consumable, 2019-2029 (USD Billion)
6.4. Cell Culture Market, Sub Segment Analysis
6.4.1. Media
6.4.2. Sera
6.4.3. Reagents
Chapter 7. Global Cell Culture Market, by Product
7.1. Market Snapshot
7.2. Global Cell Culture Market by Product, Performance – Potential Analysis
7.3. Global Cell Culture Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
7.4. Cell Culture Market, Sub Segment Analysis
7.4.1. Culture Systems
7.4.2. Incubators
7.4.3. Centrifuges
7.4.4. Cryostorage Equipment
7.4.5. Biosafety Equipment
7.4.6. Pipetting Instruments
Chapter 8. Global Cell Culture Market, by Application
8.1. Market Snapshot
8.2. Global Cell Culture Market by Application, Performance – Potential Analysis
8.3. Global Cell Culture Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
8.4. Cell Culture Market, Sub Segment Analysis
8.4.1. Biopharmaceuticals
8.4.2. Tissue Culture & Engineering
8.4.3. Vaccine Production
8.4.4. Drug Development
8.4.5. Gene Therapy
8.4.6. Cancer Research
8.4.7. Others
Chapter 9. Global Cell Culture Market, Regional Analysis
9.1. Cell Culture Market, Regional Market Snapshot
9.2. North America Cell Culture Market
9.2.1. U.S. Cell Culture Market
9.2.1.1. Consumable breakdown estimates & forecasts, 2019-2029
9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
9.2.1.3. Application breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Cell Culture Market
9.3. Europe Cell Culture Market Snapshot
9.3.1. U.K. Cell Culture Market
9.3.2. Germany Cell Culture Market
9.3.3. France Cell Culture Market
9.3.4. Spain Cell Culture Market
9.3.5. Italy Cell Culture Market
9.3.6. Rest of Europe Cell Culture Market
9.4. Asia-Pacific Cell Culture Market Snapshot
9.4.1. China Cell Culture Market
9.4.2. India Cell Culture Market
9.4.3. Japan Cell Culture Market
9.4.4. Australia Cell Culture Market
9.4.5. South Korea Cell Culture Market
9.4.6. Rest of Asia Pacific Cell Culture Market
9.5. Latin America Cell Culture Market Snapshot
9.5.1. Brazil Cell Culture Market
9.5.2. Mexico Cell Culture Market
9.6. Rest of The World Cell Culture Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Novo Nordisk A/S
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Eli Lilly and Company
10.2.3. Sanofi
10.2.4. Biocon Ltd
10.2.5. Wockhardt
10.2.6. Boehringer Ingelheim International GmbH
10.2.7. Julphar
10.2.8. United Laboratories International Holdings Limited
10.2.9. Tonghua Dongbao Pharmaceutical Co. Ltd.
10.2.10. Pfizer
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption



★調査レポート[世界の細胞培養市場2022-2029:消耗品別(培地、血清、試薬)、製品別、用途別、地域別] (コード:BZW22DV053)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の細胞培養市場2022-2029:消耗品別(培地、血清、試薬)、製品別、用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆